(2S)-1-{[(1-Amino-2-Methylpropan-2-Yl)Amino]Acetyl}Pyrrolidine-2-Carbonitrile Hydrochloride

For the synthesis of cathepsin K and L inhibitors, and as an advanced intermediate in the preparation of dipeptidyl peptidase IV (DPP-IV) antagonists bearing a nitrile warhead, (2S)-1-{[(1-Amino-2-Methylpropan-2-Yl)Amino]Acetyl}Pyrrolidine-2-Carbonitrile Hydrochloride is supplied as a lyophilized, anhydrous hydrochloride salt. The molecule combines a rigid (S)-configured pyrrolidine-2-carbonitrile core with an N-terminal glycinamide side chain capped by a sterically demanding 2-amino-2-methylpropyl (tert-leucyl) residue. This architecture positions the primary amine at a quaternary carbon center, reducing nucleophilic lability compared with unsubstituted glycinamide derivatives and suppressing premature cyano group hydration during downstream amidic coupling sequences. Batch production employs classical solution-phase peptide assembly, with the free base isolated by extraction into ethyl acetate at pH 9–10 and subsequently precipitated as the hydrochloride from methanolic HCl. The salt form increases solubility in polar aprotic media—critical for homogeneous coupling to carboxylic acid scaffolds—while maintaining a melting onset of 187–192 °C (decomposition) as determined by DSC at 10 K/min under nitrogen.

Why Is the (2S) Absolute Configuration Critical for Target Engagement?

Pyrrolidine-2-carbonitrile-based inhibitors rely on the cyano substituent to form a reversible thioimidate adduct with the active-site cysteine residue of clan CA proteases (e.g., cathepsins B, K, L, S). The stereochemistry at C-2 dictates the spatial orientation of the nitrile towards the catalytic dyad; inversion to the (R)-enantiomer typically reduces inhibitory potency by 1.5–3 orders of magnitude, as reported across multiple isoquinoline- and pyrimidine-dione-derived scaffolds in the cathepsin series. The (2S)-configured isomer described here presents the nitrile on the same face as the N-terminal substituent, matching the S₁ pocket topology of cathepsin K when coupled to a P2–P3 ligand. Enantiomeric purity is controlled by chiral stationary-phase HPLC (Chiralpak® IA-3 column, 250 × 4.6 mm, hexane/ethanol/diethylamine 80:20:0.1 v/v/v) with detection at 210 nm; the (2R)-isomer elutes as a baseline-resolved peak with a relative retention time of 1.34. Release specifications require an enantiomeric excess of ≥ 99.0%, which correlates to a specific optical rotation [α]_D²⁰ of +14.8° to +16.2° (c = 1.0 in methanol, 589 nm). Residual (R)-enantiomer above 0.5% can seed diastereomeric salt formation during subsequent coupling steps, complicating isolation of the final active pharmaceutical ingredient and lowering the diastereomeric ratio below the typical pharmacopoeial acceptance criterion of ≤ 0.15% for the undesired isomer. Upon receipt, the lyophilized hydrochloride salt is typically subjected to a panel of pharmacopoeia-aligned identity, purity, and residual solvent tests before release to Good Manufacturing Practice (GMP) synthesis campaigns. The free amine titre is determined by non-aqueous perchloric acid titration with potentiometric endpoint detection per USP <541>, yielding an on-anhydrous-basis assay of 98.5–101.0% for qualified lots. Peptide-like impurities originating from incomplete deprotection or diketopiperazine formation are separated on a C18 column (150 × 4.6 mm, 3 µm particle) using a phosphate-buffered acetonitrile gradient at 1.0 mL/min with UV absorbance at 210 nm; any single unspecified impurity is limited to ≤ 0.10% area normalisation, and total impurities to ≤ 0.5%. Water content—a critical parameter for moisture-sensitive amide coupling—is kept below 0.5% w/w by Karl Fischer coulometric titration (Ph. Eur. 2.5.32), as residual moisture above 0.8% has been correlated with a >7% yield loss in HATU-mediated conjugations run in anhydrous N,N-dimethylformamide at 0.15 M concentration. Chloride content is verified by argentometric titration against 0.1 N silver nitrate, with an acceptance range of 10.8–11.5% w/w (theoretical 11.2%). The table below collates the typical certificate-of-analysis parameters applied to research- and kilo-lab-scale deliveries.

Representative Specification Profile for Non-GMP Batches

Parameter	Method Reference	Acceptance Criterion
Appearance	Visual, USP <1079>	White to off-white lyophilised powder
Assay (anhydrous, free amine)	USP <541>, potentiometric	98.5–101.0%
Water content	Ph. Eur. 2.5.32	≤ 0.5% w/w
Chloride content	Argentometric, Ph. Eur. 2.5.24	10.8–11.5% w/w
Enantiomeric purity	Chiral HPLC-UV 210 nm	≥ 99.0% ee (2S)
Specific optical rotation	Ph. Eur. 2.2.7	+14.8° to +16.2°
Any single impurity	RP-HPLC-UV 210 nm	≤ 0.10%
Total impurities	RP-HPLC-UV 210 nm	≤ 0.50%
Residual solvents	USP <467> Procedure A	Conforms to Class 3 limits
Heavy metals	USP <231> Method II	≤ 20 ppm

Operational Boundaries During Scale-Up: Pre-drying, Light Sensitivity, and Amine Incompatibility

Kilogram-scale coupling operations using this hydrochloride salt demand strict control of water activity and nucleophile exclusion. The compound is hygroscopic; when stored at 25 °C / 60% RH for 48 hours, water uptake exceeds 2.0% w/w, sufficient to quench activated uronium coupling reagents and generate the corresponding free acid by-product. In a 50 L jacketed reactor equipped with a nitrogen sweep and a calcium chloride guard tube, pre-drying of the solid under high vacuum (< 10 mbar) at 35–40 °C for 12 hours reliably restores water content to < 0.3%. Once dissolved in anhydrous DMF (< 50 ppm H₂O by KF), the solution is used immediately; standing at ambient temperature under ambient atmosphere leads to measurable nitrile hydrolysis to the corresponding amide after 6 hours, detected as a late-eluting peak in HPLC (t_R 1.6 relative to parent). Light exposure accelerates this degradation: storage of a 0.2 M DMF solution in transparent borosilicate glass under standard laboratory fluorescent lighting (400–700 nm) yields 0.8% amide after 24 hours, whereas amber glass limits the increase to < 0.1%. The presence of a quaternary carbon-bound primary amine imposes an unusual reactivity pattern. The neopentyl-type amine possesses a pK_a of the conjugate acid estimated at ~10.2, higher than typical α-amino acid esters, which retards acylation kinetics. Under standard amide coupling conditions (HATU, 1.1 equiv; DIPEA, 3.0 equiv), complete N-acylation at 0 °C requires 4–6 hours for aliphatic carboxylic acids, compared with 1–2 hours for glycine derivatives. Attempted acceleration with excess base at temperatures above 25 °C triggers pyrrolidine ring α-epimerisation via imine-enamine tautomerisation, producing up to 3% of the (2R)-diastereomer. Consequently, process windows are narrow: coupling temperatures are maintained at 0–5 °C using a recirculating chiller with an ethylene glycol-water bath, and DIPEA equivalents are strictly limited to 2.5–3.0. Addition of exogenous nucleophilic additives—primary or secondary amines, thiols, or alkoxides—must be avoided because the cyano group is susceptible to irreversible Michael-type addition, forming stable amidine or thioimidate adducts that compete with the desired thioimidate formation at the biological target. The hydrochloride counterion partially suppresses this reactivity through protonation of the nitrile’s nitrogen lone pair in the solid state, but the free base, generated in situ upon basification, reverts to the reactive neutral species. Published stability data for the isolated free base in solution is limited, but accelerated degradation studies under simulated coupling conditions indicate that the free base generated with 3.0 equiv of DIPEA in anhydrous DMF undergoes 0.2% nitrile loss per hour at 0 °C, mandating immediate consumption after activation. Distinction from structurally analogous pyrrolidine-2-carbonitrile building blocks rests primarily on the steric bulk of the N-alkyl substituent, associated solubility profiles, and the influence of the counterion on handling. The following table contrasts the hydrochloride salt described here with the corresponding free base, the (R)-enantiomer, and the widely used (S)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile.

Comparative Properties of Pyrrolidine-2-carbonitrile Derivatives

Product	Physical Form	Solubility in DMF (25 °C)	Hygroscopicity	Typical Application
(2S)-1-{[(1-Amino-2-Methylpropan-2-Yl)Amino]Acetyl}Pyrrolidine-2-CN HCl	Crystalline powder	> 200 mg/mL	Deliquescent above 60% RH	P3-P2 amine for cathepsin K inhibitors
(2S)-1-{[(1-Amino-2-Methylpropan-2-Yl)Amino]Acetyl}Pyrrolidine-2-CN (free base)	Viscous oil	Miscible	Highly hygroscopic; must be stored under Ar	Peptide coupling in anhydrous aprotic media
(2R)-1-{[(1-Amino-2-Methylpropan-2-Yl)Amino]Acetyl}Pyrrolidine-2-CN HCl	Crystalline powder	> 200 mg/mL	Deliquescent above 60% RH	Negative control or eutomer synthesis
(2S)-1-(2-Chloroacetyl)pyrrolidine-2-CN	Waxy solid	~150 mg/mL	Low; stable at 40% RH	Electrophile for cysteine alkylation; GMP starting material for DPP-IV inhibitors

The primary advantage of the tert-leucyl amine-containing hydrochloride over the simpler chloroacetyl or glycyl analogues is the ability to introduce a quaternary carbon branching point early in the synthetic sequence, eliminating subsequent manipulation of a reactive halide or unprotected primary amine during multi-step campaigns. This pre-constructed fragment significantly reduces the number of linear steps in the convergent synthesis of cathepsin K inhibitors containing a P3 biphenyl or isoquinoline moiety—reported to lower the step count from 12 to 8 in one preclinical candidate route (published data for this specific intermediate is limited, but analogous strategy is documented in the patent literature for related pyrrolidine nitrile warheads). Nevertheless, the increased steric hindrance imposes a kinetic penalty: coupling to sterically encumbered P2 succinate or malonate derivatives may require microwave-assisted conditions (50 °C, 30 min) to achieve full conversion, whereas the glycyl analogue reacts completely under ambient conditions within 2 hours. The hydrochloride salt is preferred over the free base for long-term storage at −20 °C under argon; under these conditions, no detectable degradation (< 0.05% total impurities) occurs over 24 months, based on real-time stability monitoring of retained samples in amber glass vials with teflon-lined closures.

When the Nitrile Must Remain Unperturbed: Regulatory Considerations and Supply Chain Boundaries

Although the compound is primarily handled in research-and-development and kilo-laboratory environments, its structural relationship to late-stage cathepsin and DPP-IV inhibitor intermediates has triggered supply chain alignment with ICH Q7 active pharmaceutical ingredient (API) starting material guidelines. Suppliers providing this intermediate for CMC regulatory support typically generate a Type II drug master file (DMF) cross-referencing the synthetic route from commercial amino acid precursors (L-Proline, tert-leucine methyl ester) and include a risk assessment for potential genotoxic impurities, particularly the alkyl mesylate or tosylate that could arise from the penultimate step if methanesulfonic acid is used for deprotection. No Class 1 or Class 2 residual solvents are used in the final crystallisation, which is conducted from ethanol/methyl tert-butyl ether mixtures, and limits for ethanol (5,000 ppm) and MTBE (500 ppm) are monitored per ICH Q3C Option 1. The nitrile warhead itself is considered a structural alert for cyanide release under extreme acidic hydrolysis (refluxing 6 N HCl), but under physiological conditions and standard amide coupling pH ranges (pH 4–9), the cyano group shows no detectable solvolysis over 72 hours at 37 °C, confirmed by ¹³C NMR monitoring of the nitrile carbon at 118–120 ppm. Compliance statements for the European REACH regulation are not applicable at research-quantity thresholds (< 1 tonne per annum), but a pre-registration inquiry may be warranted for pilot-plant volumes exceeding 100 kg/year. Users are advised that the substance is not registered under TSCA active/inactive inventory for commercial manufacturing within the United States if intended for non-exempt R&D purposes, and import documentation should classify the item under Harmonized System code 2933.99.9701 for customs clearance. The hydrochloride salt is not formulated for direct human administration and bears no USP or Ph. Eur. monograph; all analytical methods described are for informational quality characterisation only.